REVIEW
Published on 20 Nov 2023
Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
doi 10.3389/fendo.2023.1187870
- 1,420 views
- 3 citations
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Radionuclide Theranostics for the Management of Endocrine Cancers
Radionuclide Theranostics for the Management of Endocrine Cancers
6,846
Total downloads
21k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 31 Oct 2022
The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
doi 10.3389/fendo.2022.941832
- 12,757 views
- 30 citations
MINI REVIEW
Published on 12 Jul 2022
Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead
doi 10.3389/fendo.2022.924841
- 3,226 views
- 5 citations
ORIGINAL RESEARCH
Published on 07 Feb 2022
[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center
![[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center](https://www.frontiersin.org/files/myhome article library/778322/778322_Thumb_400.jpg)
doi 10.3389/fendo.2022.778322
- 2,788 views
- 14 citations
Published in
Frontiers in Endocrinology
- Cancer Endocrinology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 21kTopic views
- 13kArticle views
- 6,846Article downloads